CanSino Biologics, Inc. Class H
CanSino Biologics, Inc. Class H (6185) is a biopharmaceutical company based in China, focused on the research, development, manufacturing, and commercialization of innovative vaccines for human use. The company operates within the biotechnology and pharmaceutical sectors, primarily offering a portfolio of vaccine products that address various infectious diseases, including COVID-19, tuberculosis, and meningitis. CanSino Biologics is recognized for its commitment to advancing vaccine technology and improving global public health.